scorecardresearch
Add as a preferred source on Google
Wednesday, November 19, 2025
TopicZydus Cadila

Topic: Zydus Cadila

Zydus Cadila’s Covid vaccine to be administered ‘only to adults as of now’

India's drug regulator cleared ZyCov-D for those aged 12 and above but Union Health Minister said his government does not want to make haste about administering Covid vaccines to children.

Zydus Cadila agrees to reduce Covid vaccine price but final deal yet to be reached: Sources

New Delhi: Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the...

2 months after vaccine approval, Covid shots for kids stuck on list of comorbidities, procedure

Zycov-D is the lone vaccine cleared for use in children in India. However, expert panel still thrashing out some issues to streamline the rollout for parents.

Modi govt drives hard bargain, ZyCov-D vaccine could cost Rs 275/dose or even less

The world’s first DNA vaccine for Covid manufactured by Gujarat-based Zydus Cadila is delivered using a special applicator costing Rs 30,000.

Vaccine makers upset over ‘differential pricing’ for ZyCov-D, and lack of clarity on exports

ZyCov-D has reportedly been priced by the company at Rs 1,900 for three doses while the others cost between Rs 205-215 per dose.

6 shots per patient, Rs 30,000 applicator gun complicate govt talks for ZyCov-D vaccine

World's first DNA vaccine, ZyCov-D is a 3-dose vaccine (administered in 2 injections each time) which requires a special needle-free applicator.

ZyCov-D price talks still on, but India begins training for use of needle-free applicator

First instalment of ZyCov-D, a three-dose Covid vaccine manufactured by Zydus Cadila, is expected next month. Vaccine doesn't require a needle injection to be administered.

Zycov D is 66% effective against Delta variant of SARS-Cov-2, claims Zydus Cadila

Zydus' claim comes a day after it being given emergency use authorisation in India, and is the only vaccine approved for use in 12-18 years age group.

Three-dose ZyCoV-D vaccine could be just two doses, says pharma firm Zydus Cadila

Zydus Cadilla says its test data shows that the vaccine appears to be just as effective in 2 doses as 3, and will be administered 28 days apart.

Zydus Cadila applies for approval to ZyCov-D, India’s 1st Covid vaccine tested on 12-18-yr-olds

If ZyCov-D gets the approval, it will be the fifth vaccine authorised for use in India after Covishield, Covaxin, Sputnik V and Moderna.

On Camera

After Bihar, the vote share vs seat share debate is back again. Here’s why this matters

We must first focus on the harder things that reduce the legitimacy of any election process in the eyes of the voters such as ensuring the independence of the Election Commission.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

Drone manufacturer ideaForge wins orders worth over Rs 100 crore from Army

ideaForge has formed a joint venture to manufacture and market UAVs in the US. Its Q6 UAV is now included in NATO and allied procurement systems.

INDIA has a Congress-sized hole. And the fix begins with a little humility

Without a Congress revival, there can be no challenge to the BJP pan-nationally. Modi’s party is growing, and almost entirely at the cost of the Congress.